WhatsApp
Facebook
Instagram
X (Twitter)
YouTube
LinkedIn

24/7 Customer Support

yisu enalapril maleate tablets essential hypertension renal vascular hypertension chronic heart failure 10mg shyndec enalapril maleate tablets hypertension renal hypertension chronic heart failure 10mg

Description

 Indication & Scope

YiSu®/SHYNDEC® Enalapril Maleate Tablets indicates for the treatment of essential hypertension, renovascular hypertension and chronic heart failure. It can improve cardiac function prognosis and reduce the risk of cardiovascular adverse events in heart failure patients.

  • Mechanism: Enalapril maleate is an angiotensin-converting enzyme inhibitor. It inhibits angiotensin-converting enzyme activity, blocks the conversion of angiotensin I to angiotensin II, reduces aldosterone secretion, dilates blood vessels, reduces water and sodium retention, and lowers blood pressure. It also improves ventricular remodeling and protects cardiac function in heart failure patients.
  • Drug class: Angiotensin-converting Enzyme Inhibitor (ACEI).
  • Clinical use: Clinically applied for long-term blood pressure control of various types of hypertension, adjuvant treatment of chronic heart failure to improve cardiac function and long-term prognosis, and targeted treatment of renovascular hypertension.
Specification
Generic Name Enalapril Maleate Tablets
Brand Name YiSu®; SHYNDEC®
Ingredient Enalapril Maleate
Dosage Form Tablets
Package YiSu:

5mg*8 tablets*2 blisters/box;

10mg*8 tablets*2 blisters/box

SHYNDEC:

10mg*16 tablets/box;

5mg*16 tablets/box

Conditions Treated Essential hypertension, renovascular hypertension, chronic heart failure
Taboos Contraindicated in patients with hypersensitivity to enalapril or ACEI drugs, hereditary or idiopathic angioedema, and pregnant women. Contraindicated in patients with severe bilateral renal artery stenosis
Place of origin China
Prescription type Prescription-only
Storage Conditions Store at room temperature, keep sealed and dry, protect from light and moisture
Manufacturer Yangtze River Pharmaceutical Group Jiangsu Joint Stock Co., Ltd.; Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co., Ltd.; Shanghai Shyndec Pharmaceutical Co., Ltd.
Registration Authority National Medical Products Administration (NMPA), China
Approval number H3206567; H3206568; H31021937; H31021938
Approval Date Jul 22, 2025; Jan 14, 2025
Shelf Life 24 months

How to use ?

Recommended Dose: Individualized dosage adjustment. Initial dose for hypertension is 5mg once daily, maintenance dose ranges from 10mg to 20mg daily in divided doses; low initial dose is adopted for heart failure treatment.

 

Time: Can be taken at any fixed time of the day, independent of meal time.

 

Instructions for use: Take the tablet whole with water. Start with low dose and adjust gradually according to blood pressure and cardiac function. Regular monitoring of renal function and blood potassium is required during medication.

 

Interaction: Combined with potassium-sparing diuretics or potassium supplements easily causes hyperkalemia. Concurrent use with non-steroidal anti-inflammatory drugs increases renal injury risk. Combined with other antihypertensive drugs enhances hypotensive efficacy.

 

Side effects:

1. Common side effects include dry cough, dizziness, fatigue and hypotension.

2. Rare adverse reactions include angioedema, abnormal renal function, hyperkalemia and gastrointestinal discomfort.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References
2.NMPA
3.FDA
4.EMA

FAQ

Besides hypertension, what heart disease can Enalapril Maleate Tablets treat?

It can treat chronic heart failure and help improve long-term cardiac function prognosis of patients.

What is the most common adverse reaction of Enalapril Maleate Tablets?

Persistent dry cough that is not caused by cold is the most typical common side effect of the drug.

Who is forbidden to use Enalapril Maleate Tablets this enalapril tablet?

Pregnant women, people with drug allergy and patients with severe bilateral renal artery stenosis cannot use it.

Is meal time a factor affecting medication effect of Enalapril Maleate Tablets?

Medication time is not affected by meals, and the drug can be taken at any fixed time daily.

YiSu® | Enalapril Maleate Tablets | Essential Hypertension/Renovascular Hypertension/Chronic Heart Failure | DengYueRX

INN: Enalapril Maleate Tablets
Indications: Essential hypertension, renovascular hypertension and chronic heart failure
Dosage Form: Tablets
Strength: 10mg/tablet

Price range: $0.71 through $1.39

Low MOQ

WHO-GMP

Worldwide Delivery

Compliance and Regulatory Documents

Related Products

Scroll to Top

Your Cart

Your Cart

Your Cart is Empty

Start Shopping
Continue Shopping
Payment Details
Sub Total $0.00